This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting galley proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. scandens showed no different relative risk with NSAIDs. The major adverse events were gastrointestinal symptoms.
ConclusionD. scandens may be considered as an alternative for musculoskeletal pain reduction.
3
Graphical abstractAbbreviations